Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mahmood

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
JPMA. the Journal of the Pakistan Medical Association|October 16, 2003
Cefaclor AF vs Clarithromycin in acute exacerbation of chronic bronchitis (B3M-PK-AJBG)S Khan, A Javaid, R A Ghori, et al.
Clinical Immunology (Orlando, Fla.)|April 23, 2022
TNF-inhibitors or bisphosphonates in chronic nonbacterial osteomyelitis? - Results of an international retrospective multicenter studyA Schnabel, M Nashawi, C Anderson, et al.
The Journal of Infectious Diseases|March 18, 2000
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccineR B Belshe, W C Gruber, P M Mendelman, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
JPMA. the Journal of the Pakistan Medical Association|October 16, 2003
Cefaclor AF vs Clarithromycin in acute exacerbation of chronic bronchitis (B3M-PK-AJBG)S Khan, A Javaid, R A Ghori, et al.
Clinical Immunology (Orlando, Fla.)|April 23, 2022
TNF-inhibitors or bisphosphonates in chronic nonbacterial osteomyelitis? - Results of an international retrospective multicenter studyA Schnabel, M Nashawi, C Anderson, et al.
The Journal of Infectious Diseases|March 18, 2000
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccineR B Belshe, W C Gruber, P M Mendelman, et al.
Pageof 10